Geographic Atrophy
Geographic atrophy (GA) is an advanced form of dry age-related macular degeneration (AMD), marked by the gradual death of retinal cells, particularly within the macula, the region responsible for sharp, central vision. As these cells deteriorate, the ability to perceive fine detail and contrast steadily declines. Over time, distinct areas of retinal damage form, giving the disease its “geographic” appearance when viewed during clinical examination.
Unlike wet AMD, which is caused by abnormal blood vessel growth beneath the retina, GA progresses through the slow and irreversible loss of retinal tissue. This degeneration affects millions of people worldwide, most often those aged 65 and older. As the global population ages, the prevalence of GA is expected to increase significantly, presenting one of the most pressing unmet needs in ophthalmology today.
At Vision BioSciences, we are developing regenerative therapeutics designed to address the underlying cellular degeneration that defines GA. Our scientific platform focuses on exploring regenerative pathways and gene-based approaches that may restore or replace damaged retinal cells and help preserve visual function. By combining deep expertise in retina and vitreoretinal science with decades of experience in clinical research, we are working to move regenerative vision science from concept to reality.
While there is currently no cure for geographic atrophy, our mission—to restore vision through regenerative therapeutics—drives us to pursue treatments that have the potential to not only slow disease progression but also restore sight and quality of life for those affected.
